Project Details
Description
A Phase IIa, Randomized, Parallel, Double-Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Enpatoran in Dermatomyositis and Polymyositis Participants receiving Standard of Care
Status | Active |
---|---|
Effective start/end date | 10/7/22 → 10/31/27 |
Funding
- EMD SERONO RESEARCH & DEVELOPMENT INST
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.